Pathway identification through transcriptome analysis
Authors:
- 7 July 2020
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 74, 109701
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 85 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Network Analysis of a Pkd1-Mouse Model of Autosomal Dominant Polycystic Kidney Disease Identifies HNF4α as a Disease ModifierPLOS Genetics, 2012
- Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney diseaseBMC Systems Biology, 2011
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networksHuman Molecular Genetics, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Periostin induces proliferation of human autosomal dominant polycystic kidney cells through αV-integrin receptorAmerican Journal of Physiology-Renal Physiology, 2008
- Gene expression in early and progression phases of autosomal dominant polycystic kidney diseaseBMC Research Notes, 2008
- A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1Nature Medicine, 2007
- Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathwayHuman Molecular Genetics, 2007